Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Approach
3.2. Snippet by Vector Type
3.3. Snippet by Technique
3.4. Snippet by Application
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising funding and investments by the government and companies for gene therapy research
4.1.2. Restraints
4.1.2.1. High developmental and treatment costs
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. By Approach
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Approach
6.1.2. Market Attractiveness Index, By Approach
6.2. Ex-Vivo*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. In-Vivo
7. By Vector Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Vector Type
7.1.2. Market Attractiveness Index, By Vector Type
7.2. Viral Vectors*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.2.3. Retrovirus
7.2.4. Lentivirus
7.2.5. Adeno-Associated Virus
7.2.6. Herpes Simplex Virus
7.2.7. Others
7.3. Non-Viral Vectors
8. By Technique
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
8.1.2. Market Attractiveness Index, By Technique
8.2. Gene Replacement*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Gene Addition
8.4. Gene Editing
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Oncology*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Musculoskeletal Conditions
9.4. Blood Disorders
9.5. Rare Diseases
9.6. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Approach
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Vector Type
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. The U.S.
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Approach
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Vector Type
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. UK
10.3.7.3. France
10.3.7.4. Italy
10.3.7.5. Spain
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Approach
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Vector Type
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Approach
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Vector Type
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. South Korea
10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Approach
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Vector Type
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Novartis AG*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Ferring Pharmaceuticals Inc.
12.3. Vertex Pharmaceuticals Incorporated
12.4. CSL Behring LLC
12.5. Amgen, Inc.
12.6. Orchard Therapeutics plc
12.7. Krystal Biotech, Inc.
12.8. Spark Therapeutics, Inc.
12.9. bluebird Bio, Inc.
12.10. Sarepta Therapeutics, Inc.
12.11. Other Players
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us